SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,560.00    110.00 (2.47%)
Bid:
4,530.00
Ask:
4,590.00
Spread: 60.00 (1.325%)
Market Cap: £303.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Statement

18 Jul 2012 07:00

RNS Number : 8953H
Judges Scientific PLC
18 July 2012
 

 

 

Judges Scientific plc

Trading Statement

18 July 2012

Judges Scientific plc ('Judges Scientific', the 'Company' or the 'Group')

Trading Update

The Directors of Judges Scientific, the parent company of a group engaged in the design, manufacture and sale of scientific instruments, are pleased to update shareholders and the market with regard to the Group's trading performance during the first half of the current financial year.

The Group recorded a solid trading performance during the period to 30 June 2012. The interim results, scheduled to be announced in September, are expected to show organic revenue growth of almost 8% compared with the six months to 30 June 2011. This advance in revenue increases to 39% when account is taken of businesses purchased since 1 January 2011, including a full six months of turnover from Deben and a first time contribution from Global Digital Systems ("GDS") and KE Developments ("KED"). The Board anticipates that interim profits and earnings per share before exceptional items will reflect this satisfactory performance.

GDS and KED were acquired on 6 March 2012 and both have since traded in line with management's expectations. The KED business was successfully relocated into Deben's Woolpit premises during the course of June 2012.

Order intake during the six-month period showed organic growth of 14%. The order book at 30 June 2012 represented ten weeks of sales, somewhat ahead of the level at the beginning of the year, partly as a result of the strong order intake and partly due to the fact that GDS's order book tends to be longer than the Group average.

The balance sheet will show a comfortable cash surplus as at 30 June 2012. Net debt had been eliminated altogether by the end of February, before £8.0 million was borrowed in March to finance the acquisition of GDS. However, the share placing in May raised £2.8 million (net) and this can be assumed to have reduced the level of gearing to less than one-times pro-forma historic EBITA.

The Board continues to be mindful that the global economic climate is fraught with uncertainty. Public spending restraint in Europe, the strength of Sterling, the embattled status of the Euro and fears of deceleration in China are all factors which are capable of affecting our businesses. There can be no complacency and the Board views the current trading environment with balanced measures of vigilance and confidence.

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

Pascal Keane, Edwards Mansfield, Shore Capital: Tel: 020 7408 4090

Melvyn Marckus, Cardew Group: Tel: 07775 896 491

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGMNRNRGZZM
Date   Source Headline
16th Mar 20062:25 pmRNSNotice of Preliminary Results
28th Feb 200611:42 amRNSAdditional Listing
23rd Feb 20066:15 pmRNSDirector/PDMR Shareholding
22nd Feb 20067:01 amRNSAcquisition
24th Nov 20057:01 amRNSClarification of Holding
16th Nov 200510:55 amRNSHolding(s) in Company
24th Oct 200512:03 pmRNSAppointment of Director
27th Sep 20057:01 amRNSDirector/PDMR Shareholding
15th Sep 20057:01 amRNSInterim Results
5th Sep 20051:25 pmRNSAcquisition
17th Jun 20055:22 pmRNSHolding(s) in Company
27th May 20057:00 amRNSHolding(s) in Company
23rd May 20055:20 pmRNSResult of EGM
6th May 200510:43 amRNSSchedule 1 - Judges Capital
29th Apr 20057:02 amRNSAcquisition and Placing
29th Apr 20057:02 amRNSFinal Results and Acquisition
14th Jan 20058:38 amRNSHolding(s) in Company
10th Jan 20059:30 amRNSSale of investment
10th Jan 20059:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.